Please provide your email address to receive an email when new articles are posted on . NEW YORK — Advancements in cross-linking will involve performing the procedure with the epithelium on, Mitch ...

The first patient has been treated in a first-in-human clinical trial investigating the safety and efficacy of the CXLens ...

Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

There is no cure for keratoconus, but the cornea can be strengthened to slow or halt the progression of the disease with an FDA-approved cross-linking procedure called iLink®. Once diagnosed, there is ...

The aim of the procedure – which is sometimes known as CXL – is to stop your keratoconus getting any worse by making the cornea stiffer. It isn't clear exactly how it works but it might make the bonds ...